Home › Funds › Squadron Capital Management LLC › DFTX

Squadron Capital Management LLC position in DFTX

DEFINIUM THERAPEUTICS INC · Health Care

Squadron Capital Management LLC reported holding 340,000 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.9M, representing 5.13% of its reported portfolio and ranking #6 among its reported holdings. Squadron Capital Management LLC has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)340.00K sh
Reported value held$12.94M
Portfolio Weight5.13%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Squadron Capital Management LLC's DFTX position evolved

Squadron Capital Management LLC first disclosed a stake in DFTX in Q2 2026 at 85,000 shares (US$4.0M). The position peaked in Q3 2026 at 340,000 shares, worth US$12.9M. Across 2 filings, Squadron Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 340,000 shares valued at US$12.9M — an increase of 255,000 shares quarter over quarter.. Notable position changes include a 300% increase in Q3 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 85.00K $4.00M New
Q3 2026 340.00K $12.94M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DFTX and 13F data

DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 112 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$268.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$258.4M), Octagon Capital Advisors LP (US$95.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DFTX

All DFTX fund holders →

FAQ

How long has Squadron Capital Management LLC held DFTX?

Squadron Capital Management LLC has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Squadron Capital Management LLC's current position in DFTX?

As of Q3 2026, Squadron Capital Management LLC holds 340.00K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $12.94M, representing 5.13% of its reported portfolio and ranking #6.

Has Squadron Capital Management LLC been buying or selling DFTX?

In the latest 13F filing (Q3 2026), Squadron Capital Management LLC increased its position in DFTX. The position peaked in Q3 2026 at 340.00K shares.

Which other funds hold DFTX?

Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 112 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.